Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (11-20 of 351) with videos related to

Pageof 36
Sort By:
Cancer Research|July 25, 2012
Changing the tumor microenvironment: new strategies for immunotherapyPedro Berraondo, Viktor Umansky, Ignacio Melero
Cancer Cell|March 15, 2024
The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapyPedro Berraondo, Gabriel Gomis, Ignacio Melero
Current Pharmaceutical Design|July 23, 2003
Gene therapy of cancer with interleukin-12Guillermo Mazzolini, Jesús Prieto, Ignacio Melero
Medicina|March 24, 2004
[Role of interleukin-12 in cancer immunotherapy]Guillermo Mazzolini, Ignacio Melero, Jesús Prieto
Immunity|March 17, 2016
Cancer Immunosurveillance Caught in the ActPedro Berraondo, Alvaro Teijeira, Ignacio Melero
Oncoimmunology|June 5, 2013
High-density lipoproteins delivering interleukin-15Maria C Ochoa, Ignacio Melero, Pedro Berraondo
Frontiers in Immunology|June 9, 2020
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune CheckpointJörg Wischhusen, Ignacio Melero, Wolf Herman Fridman
Nature Medicine|June 25, 2025
Antigen-presenting mast cells are new players in breast cancer immunotherapyCarlos Luri-Rey, Álvaro Teijeira, Ignacio Melero
Current Gene Therapy|February 7, 2006
Gene therapy of cancer based on interleukin 12Bruno Sangro, Ignacio Melero, Cheng Qian, et al.
Genes and Immunity|March 9, 2024
Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancerIgnacio Melero, Carmen Molina, Cristina Eguizabal, et al.
Pageof 36

Showing results (11-20 of 351) with videos related to

Sort By:
Pageof 36
Cancer Research|July 25, 2012
Changing the tumor microenvironment: new strategies for immunotherapyPedro Berraondo, Viktor Umansky, Ignacio Melero
Cancer Cell|March 15, 2024
The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapyPedro Berraondo, Gabriel Gomis, Ignacio Melero
Current Pharmaceutical Design|July 23, 2003
Gene therapy of cancer with interleukin-12Guillermo Mazzolini, Jesús Prieto, Ignacio Melero
Medicina|March 24, 2004
[Role of interleukin-12 in cancer immunotherapy]Guillermo Mazzolini, Ignacio Melero, Jesús Prieto
Immunity|March 17, 2016
Cancer Immunosurveillance Caught in the ActPedro Berraondo, Alvaro Teijeira, Ignacio Melero
Oncoimmunology|June 5, 2013
High-density lipoproteins delivering interleukin-15Maria C Ochoa, Ignacio Melero, Pedro Berraondo
Frontiers in Immunology|June 9, 2020
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune CheckpointJörg Wischhusen, Ignacio Melero, Wolf Herman Fridman
Nature Medicine|June 25, 2025
Antigen-presenting mast cells are new players in breast cancer immunotherapyCarlos Luri-Rey, Álvaro Teijeira, Ignacio Melero
Current Gene Therapy|February 7, 2006
Gene therapy of cancer based on interleukin 12Bruno Sangro, Ignacio Melero, Cheng Qian, et al.
Genes and Immunity|March 9, 2024
Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancerIgnacio Melero, Carmen Molina, Cristina Eguizabal, et al.
Pageof 36